
|
|
|
Natural
Medicines in Clinical Management of Colds and
Flu | |
Causes
of Colds and Flu | Pathogenesis |
Prevention
of Colds and Flu Treatment
of Colds and Flu | The
Bottom Line |
|
The "common" cold is aptly named...it is
something nearly everyone encounters. The U.S.
population experiences nearly a billion colds annually.
Children usually have about six to ten colds per
year...adolescents and adults have about two to four.
Adults over 60 typically have less than one cold per
year.10762,10763
Influenza ("the flu") is much more
serious...and much less common than the common cold.
Each year 35-50 million people in the U.S. get the flu.
Most people recover. But the flu still causes
complications, which lead to 100,000 hospitalizations
and more than 50,000 deaths each
year.10764 | |
|
|
| Causes of Colds and Flu |
 |
| |
More than 200 different viruses can cause
the common cold. The rhinovirus is the most common. It's
responsible for 30% to 50% of all colds. It is spread
both by contact and through airborne transmission.
Rhinovirus infections can occur throughout the year but
peak between April and May, and again in
September.10765 In autumn, rhinoviruses cause
80% of all upper respiratory
infections.10766
| Viruses that Cause the Common
Cold10765,10766 |
|
Virus |
Percentage of
cases |
|
Rhinoviruses |
30 to 50 |
|
Coronaviruses |
10 to 15 |
|
Parainfluenza virus |
5 |
|
Respiratory syncytial virus
(RSV) |
5 |
|
Adenovirus |
<5 |
|
Enterovirus |
<5 |
|
Unknown |
20 to 30 |
The flu is caused by 3 types of
viruses...influenza A, influenza B, and influenza C. The
influenza A virus is responsible for pandemics...flu
outbreaks that spread worldwide. Influenza A causes
severe disease and a significant number of deaths, even
in young people. The influenza B virus doesn't cause
pandemics, but can cause severe disease in the elderly
and other high-risk patients. Influenza C causes mild
disease with no seasonal variation.10767
Flu season typically lasts from November
to March. Different vaccines are needed every year
because of changes in viral proteins, especially in
influenza A. Two proteins on the surface of the virus
facilitate viral spread in the respiratory tract. These
proteins can change. The changes produce what looks like
a new virus to the immune system. Each time this happens
the population doesn't have immunity to the "new" virus.
This means the influenza virus reinvents itself to some
degree every year or every few years. The greater the
changes, the greater the risk for a
pandemic.10767
Each year's flu vaccine is an educated
guess by the U.S. Public Health Advisory Committee on
Immunization Practices. This group predicts which
viruses are likely to cause disease in the upcoming flu
season. This decision is made 6-9 months in advance to
allow production time for vaccines. A faulty prediction
can result in a vaccine which doesn't protect against
the season's prevalent influenza
strains.10767
Cold and flu viruses are usually
transmitted by hand contact with secretions that contain
the virus...either directly from an infected person or
indirectly from environmental surfaces such as
telephones and doorknobs. Subsequent rubbing of the eye
or nose can lead to infection.10763,10766
Viral transmission can also occur by
inhalation. Aerosols from an infected person enter the
respiratory tract of a new host and begin colonization.
Small-particle aerosols, which are thought to be the
means of influenza and adenovirus transmission, can
linger in the air for an extended period of
time.10763,10766
There are a lot of myths about causes of
the cold and flu. For example, some people believe
becoming chilled or wet can cause a cold or flu. But
this isn't true.10766 It may be the common
timing of cool weather and peak flu season. Cold weather
tends to keep people inside where exposure to infected
individuals can occur more easily.
Some people think smokers have more colds.
Actually, cigarette smoking doesn't affect the incidence
of colds and flu. But smokers do have more severe
symptoms and longer duration of symptoms than
nonsmokers.10763,10769 The effect of
stress on the immune system is controversial. Some
evidence suggests psychological stress might increase
the risk of catching a cold.10771,10772 But
other research suggests stress or a "weak immune system"
doesn't seem to cause infections in healthy people. When
exposed to a cold virus under experimental conditions,
nearly everyone becomes infected.10768
| |
|
 |
| Question
#1 |
| Cases of the
common-cold can occur throughout the year. But
what is the PEAK time of year for
colds? |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
| Question
#2 |
| Which of the following
is usually responsible for influenza
pandemics? |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
| Question
#3 |
| Which of the following
INCREASES the risk of cold virus infection in
adults? |
|
|
|
|
|
|
|
|
|
|
|
| | | |
| Pathogenesis |
 |
| |
Viruses colonize respiratory cells,
triggering the release of histamine, leukotrienes,
interleukins, tumor necrosis factor, and other
cytokines. The flu viruses cause extensive damage to the
respiratory epithelium. In contrast, cold-causing
rhinoviruses themselves don't cause changes to
respiratory tissue. Rhinovirus symptoms may be caused by
the body's own inflammatory response to the
virus.10763,10766
Colds typically begin with sore or
scratchy throat, sneezing, nasal discharge and
stuffiness.10763,10766 Otitis and sinusitis
can sometimes follow a cold. The flu often begins with a
sudden headache, fever, myalgia, and
malaise.10767 Influenza complications include
viral and secondary bacterial
pneumonia.10763,10766
| Symptoms of Colds and
Influenza10770,10771 |
|
Symptom |
Common Cold |
Influenza |
| Onset |
gradual |
abrupt |
|
Headache |
mild, uncommon |
severe, common |
|
Fever |
uncommon or 0.5° (1° F)
increase |
common 37.7° to 40° C (100° to 104°
F) |
|
Myalgia, arthralgia |
uncommon |
common |
|
Malaise |
mild |
severe |
|
Fatigue, weakness |
very mild, short duration |
common, lasts 2 to 3 weeks |
|
Cough (dry) |
mild to moderate |
common, severe |
|
Chest discomfort |
mild to moderate |
common, severe |
|
Anorexia |
uncommon |
common |
|
Nasal congestion |
common |
uncommon |
|
Sneezing |
common |
occasional |
|
Sore throat |
common |
occasional |
| Commonly Used Conventional and
Natural Medicines for Colds and Influenza* |
Vaccines Influenza
vaccine (FluShield,
Fluzone, Fluvirin, FluMist)
|
Antivirals Conventional
medicines Amantadine
(Symmetrel) Oseltamivir
(Tamiflu) Rimantadine
(Flumadine) Zanamivir
(Relenza) Natural
medicines Elderberry (Sambucus
nigra) Garlic (Allium
sativum) Zinc
|
Immunomodulators Andrographis (Andrographis
paniculata) Astragalus (Astragalus
membranaceus) Boneset (Eupatorium
perfoliatum) Elderberry (Sambucus
nigra) Essential fatty
acids (linoleic acid, alpha-linolenic
acid) Goldenseal (Hydrastis
canadensis) Garlic (Allium
sativum) Lactobacillus
rhamnosus Larch
arabinogalactan (Larix
occidentalis) Multivitamins
and minerals Oscillococcinum Panax
ginseng Pau d'arco (Tabebuia
impetiginosa) Propolis Selenium Siberian
ginseng (Eleutherococcus
senticosus) Vitamin
C Vitamin
E Wild indigo (Baptisia
tinctoria) Zinc
|
Antihistamines First
generation
antihistamines (chlorpheniramine,
clemastine, diphenhydramine,
etc)
|
Decongestants Naphazoline
(Privine) Oxymetazoline
(Afrin) Phenylephrine
(Neo-Synephrine
4-Hour) Propylhexedrine
(Benzedrex) Pseudoephedrine
(Sudafed) Xylometazoline
(Otrivin)
|
Anticholinergics Ipratropium
(Atrovent)
|
Anti-inflammatories Echinacea (Echinacea
angustifolia, Echinacea
pallida, Echinacea
purpurea) Nonsteroidal
anti-inflammatory drugs
(NSAIDs) (ibuprofen,
naproxen, etc)
|
Miscellaneous Saline
nasal spray or drops
|
*Note: Many natural products are tried for
colds and flu, but very few have reliable evidence that
they work. Inclusion in this list does NOT imply that
these products are effective for colds or
flu. | |
|
 |
| Question
#4 |
| Which of the following
symptoms would be LEAST likely in the common
cold? |
|
|
|
|
|
|
|
|
|
|
|
| | | |
| Prevention of Colds and Flu |
 |
| |
Vaccines
The development of a vaccine against
cold-causing rhinoviruses is unlikely. There are many
different types of rhinovirus. These different types
don't share enough in common to create an effective
vaccine.
Several vaccines against other
cold-causing viruses, Respiratory syncytial virus (RSV)
and parainfluenza virus are in early clinical
trials.10766 There are options already
available for high-risk neonates and children up to age
two...the RSV vaccine (palivizumab, Synagis) and
the RSV immune globulin (RespiGam).
There are many more options available for
preventing the flu. Flu vaccines are very effective.
They can prevent severe disease, hospitalization, and
death. In fact, the U.S. Centers for Disease Control and
Prevention encourages vaccination for EVERYONE over 6
months of age, except for those with
contraindications.
| A flu shot is a
"must" for people in high risk
groups:10773 |
- all adults age 50 and older
- pregnant women who will be in their second
or third trimester during flu season
- residents of long-term care facilities
- patients with chronic conditions such as
lung disorders, including asthma, heart
disorders, diabetes, renal dysfunction
- immunocompromised patients
- children age 6 months to 18 years who are on
long-term aspirin therapy
- healthcare workers
- household contacts of high-risk patients
|
Most people should get flu immunizations
in October and November. Patients are usually protected
within 2 weeks of the shot and it lasts for about 6
months. Flu vaccines (FluShield, Fluzone,
Fluvirin) are trivalent...each includes two
influenza A strains and one influenza B
strain.10773
Children age 9 and under who are receiving
a flu shot for the first time should receive 2 shots
spaced a month apart.10767 More than one flu
vaccine per year in adults provides no additional
benefit.10861,10862
| Practice
Pearl |
| A common myth is that flu shots
can cause the flu. Tell patients that flu shots
DON'T cause the flu. Explain that they sometimes
cause flu-like SYMPTOMS. About 5% to 10% of people
have mild side effects such as headache or
low-grade fever for about a day after
vaccination. |
FluMist is a new intra-NASAL
vaccine. FluMist contains live attenuated flu
viruses. Traditional influenza vaccines contain
inactivated influenza viruses. FluMist is NOT
recommended for people under age 5 or over age 49,
pregnant women, or patients with chronic disease.
Since FluMist is a live-virus
vaccine, it can't be given to immunocompromised patients
or their caregivers. This is because someone receiving a
live-virus vaccine might transmit virus to an
immunocompromised patient. The flu SHOT may be preferred
for family members, healthcare workers, and other close
contacts of immunocompromised patients.10774
Antivirals
Antiviral drugs can be used as
alternatives to flu immunization for patients who can't
get a flu vaccine. Though they must be used throughout
flu season to prevent the flu. Amantadine
(Symmetrel) and rimantadine (Flumadine)
inhibit the growth of influenza A. But they aren't
effective against influenza B. Their use is also
limited, particularly amantadine, by adverse
effects...insomnia...restlessness...
anxiety.10775,10776
Relenza (zanamivir) and
Tamiflu (oseltamivir) are a newer class of
antivirals...neuraminidase inhibitors. They prevent
viruses from penetrating the surfaces of healthy cells
and inhibit the release of viruses from infected cells.
Zanamivir and oseltamivir seem to
be equally effective. The neuraminidase inhibitors may
be better tolerated than the older antivirals. Zanamivir
and oseltamivir are effective against both influenza A
and B.10775,10776
Zinc is sometimes used to
prevent colds. Zinc inhibits rhinovirus replication
in vitro, but there's no evidence this happens
in vivo. There's no evidence zinc is effective
for preventing colds. 10780,10783,10784 Tell
patients dietary or supplemental zinc won't PREVENT
colds.
Immunomodulators
Many people try natural products promoted
to "boost or support the immune system." But this
approach may not offer much help. Some research suggests
that a virus's ability to infect a host may be MORE
important than immune system function in catching a cold
or flu.10768 In other words, a virus may be
able to cause illness even in the presence of a healthy
immune system.
Andrographis
(Andrographis paniculata), also known as "Indian
echinacea," is used to prevent both colds and flu.
Andrographis is thought to have immunostimulant
properties.2766 There's some preliminary
evidence that suggests andrographis might reduce the
risk of catching a cold. But it can take two months of
treatment to see this benefit.2772 And it's
unclear how long this benefit lasts. It's too soon to
recommend it.
Astragalus (Astragalus
membranaceus) is a Chinese herb promoted to prevent
colds and flu. There's some evidence astragalus can
stimulate lymphocyte production.3713,10777
But there's no clinical evidence it's effective for cold
or flu prevention. Don't recommend astragalus.
Echinacea (Echinacea
angustifolia, Echinacea pallida, Echinacea purpurea)
is widely used to prevent upper respiratory infections
including colds and flu. In vitro research
suggests that echinacea stimulates the immune system,
causing macrophages to produce tumor necrosis factor,
interleukin-1, and beta-interferon.6388,6389
But echinacea does not seem to be effective for
preventing colds.3281,3282,6386,10782 Don't
recommend echinacea for PREVENTING colds and flu.
For the latest on Echinacea, see "Echinacea for the Common Cold,"
Detail-Document #210911.
| Practice
Pearl |
| Tell patients trying to conceive
NOT to use echinacea or andrographis. There's some
concern these herbs might decrease fertility by
decreasing sperm motility and decreasing oocyte
fertilization.4239,4240 These effects
haven't been demonstrated in humans, but couples
trying to conceive should avoid echinacea and
andrographis until more is
known. |
Garlic (Allium
sativum) is tried for preventing colds. Garlic has
immunostimulant activity and might also have antiviral
activity. There's some evidence that allicin-containing
garlic SUPPLEMENTS reduce the risk of catching a
cold.10787 Allicin is the active component in
garlic. Patients taking daily supplements between
November and February have one fewer cold than patients
taking placebo.10787 But there's not enough
evidence to recommend garlic for preventing colds.
Garlic has dose-related adverse
effects...most commonly bad breath and body odor. Tell
patients taking warfarin that garlic can increase their
INR.616,4802,4803
Panax ginseng might
have immunostimulant effects. Some clinical evidence
suggests that Panax ginseng might protect against
colds and improve response to the flu vaccine. When
Panax ginseng 100 mg per day is started 4 weeks
prior to influenza vaccination and continued for 8 weeks
thereafter, it seems to reduce the risk of contracting
both the cold and flu. The mechanism for this effect is
unknown, but Panax ginseng might increase natural
killer cell activity and the antibody response to
vaccination.589 There's not enough evidence
to recommend Panax ginseng for this use. Panax
ginseng is usually well-tolerated. Insomnia is the
most common complaint. The safety of long-term use is
unknown. Tell patients to limit Panax ginseng use
to 3 months.589
The brand Cold-fx is getting lots
of attention. For the latest on North American ginseng
(Panax quinquefolium), see "North American Ginseng Extract
(Cold-fX) for the Common Cold,"
Detail-Document #211212.
Some research suggests that milk fortified
with the GG strain of Lactobacillus
rhamnosus can modestly reduce the incidence
of respiratory infections in young children in day
care.8565 Lactobacillus GG might
stimulate immune function.4399 It appears to
increase phagocytic activity of
leukocytes.7756,7757 Other research suggests
a combination of the essential fatty acids linoleic acid and alpha-linolenic acid can
reduce respiratory infections in children. These fatty
acids might have a beneficial effect on immune
function.10785 But in adults, dietary fatty
acids don't seem to affect immune response to bacterial
infection.10786 Don't recommend lactobacillus
or fatty acids to prevent respiratory infections.
Multivitamin-mineral supplements
don't seem to affect the incidence of acute
respiratory infections. Supplemental vitamin E doesn't lower the
risk of infection. But it might reduce the severity of
illness.10788 Supplementation with zinc and selenium might improve
antibody response to the flu vaccine in elderly patients
with mineral deficiencies.6553 But there's no
evidence that zinc and selenium supplementation helps
healthy patients with adequate dietary intake. Tell
patients there's no evidence multivitamins or minerals
prevent colds and flu.
Vitamin C has long been
promoted for colds and flu...and has generated lots of
controversy. Vitamin C might help immune function. It
seems to increase T-lymphocyte activity, phagocyte
function, leukocyte mobility, and possibly antibody and
interferon production.1963,1965 But most
evidence suggests that even in doses up to 1 gram per
day, vitamin C does NOT prevent
colds.1967,6458,9832 Likewise DIETARY vitamin
C intake doesn't seem to affect the risk of getting a
cold.10780
Suggest to patients interested in using
vitamin C to get five servings of fruits and vegetables
per day. This provides about 200 mg of vitamin C which
is adequate for good nutrition.3042
| Practice
Pearl |
Tell patients ANY handwashing is
good to prevent the spread of cold viruses.
Alcohol-based hand gels (Purell) seem to be
more effective than water for
handwashing...because it takes less time than a
1-2 minute soap and water scrub. There's some
evidence that alochol-based hand gels, which
contain 62% ethyl alcohol, lower the amount of
cold-causing viruses on fingers better than water
alone.10863,10865 Alcohol hand
sanitizers are a good option when handwashing is
inconvenient. |
| |
|
 |
| Question
#5 |
| Which of the following
is NOT recommended for those over age
49? |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
| Question
#6 |
| What should you tell
patients about zinc for PREVENTING
colds? |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
| View brands
containing: |
| - |
Zinc | |
 |
|
|
 |
|
|
 |
|
|
 |
|
|
 |
| Question
#7 |
| Which of the following
is most likely to relieve cold
symptoms? |
|
|
|
|
|
|
|
|
|
|
|
| | | |
| Treatment of Colds and Flu |
 |
| |
Antivirals
Treatment of the common cold with
antivirals has not been successful so far. On the other
hand, treatment of the flu with antiviral drugs is well
established. Amantadine and rimantadine are used to
treat influenza A, but viral resistance can develop in
about 25% to 35% of patients.
The neuraminidase inhibitors...oseltamivir
and zanamivir... are effective for both influenza A and
B. When treatment with neuraminidase inhibitors is begun
within 48 hours of the onset of symptoms, the duration
of the flu is cut by one to two days.10766
Neuraminidase inhibitors also decrease the risk of flu
complications such as pneumonia and otitis
media.10776,10791 Significant viral
resistance has not been reported for these newer
antivirals.10775
| Practice
Pearl |
| Remind patients that colds and
influenza are caused by viruses. Antibiotics are
effective only against bacteria. There is no
evidence that antibiotics shorten the duration or
lessen the symptoms of a cold or flu. Caution that
overuse of antibiotics promotes bacterial
resistance.11101,11102,11103 |
Antihistamines
Conventional treatment of colds is
symptomatic. First-generation
antihistamines...chlorpheniramine and clemastine...can
decrease sneezing and rhinorrhea, probably because of
their anticholinergic activity.10766,10792
Drowsiness is a prominent side effect, however.
Second generation antihistamines (loratadine,
fexofenadine, etc) aren't effective for symptomatic
relief because they have hardly any anticholinergic
activity.
Decongestants, Anticholinergics, and
Anti-inflammatories
Oral or intranasal decongestants can
dilate nasal passages.10766 Tell patients to
limit intranasal decongestant use to three to five days
to avoid rebound congestion. Intranasal ipratropium
(Atrovent nasal spray) also relieves sneezing and
rhinorrhea associated with colds.10793 NSAIDs
have shown effectiveness in reducing cough, possibly by
blocking prostaglandin action. NSAIDs are also useful
for headache, malaise, sore throat pain, and other
systemic
complaints.10763,11104,11105,11106,11107 But
oral or intranasal steroids, with more potent
anti-inflammatory activity, are not clinically useful
for treating colds.10766Antitussives and
mucolytic agents are frequently used, but their efficacy
in colds is unproven.10794 Even codeine seems
to be no more effective than placebo for treating coughs
associated with colds.11110
Immunomodulators
Lots of people take natural medicines to
TREAT the common cold and influenza. Unlike conventional
treatment, which is primarily directed at symptoms, many
natural medicines are used to "strengthen the immune
system."
Andrographis seems to
significantly improve symptoms of the common cold when
started within 72 hours of symptom onset. Some symptoms
can improve after two days of treatment, but it
typically takes four to five days before maximal symptom
relief. Andrographis doesn't seem to help cough. Most
studies have used the proprietary product Kan Jang,
standardized to contain 4-5.6 mg of the andrographolide
per tablet. Tell patients wanting to use andrographis to
stick to products standardized to 4-5.6 mg of
andrographolide. The safety of more concentrated
products is not
known.2744,2773,2774,5784,10795
Echinacea is frequently used
alone or in combination with other herbs to treat colds
and flu. Although it's commonly thought of as an
immunostimulant, echinacea might actually have
anti-inflammatory effects.10797,10798,10799
Theoretically, echinacea might reduce cold symptoms via
anti-inflammatory activity similar to NSAIDs.
Most studies show that echinacea can
reduce symptom severity and duration from 10% to
30%.1412,6384,6386,6392, 8228,10782,10802 The
active constituent(s) isn't known, so products used in
research are not standardized.10800 Dose can
also vary by product. For example, a tablet containing
6.78 mg of Echinacea purpurea crude extract based
on 95% herb and 5% root (Echinaforce, Bioforce
AG) is dosed as two tablets given three times
daily.1412 Another example is
Echinacea purpurea herb juice. It's used in a
daily dose of 6-9 mL. Tell patients that echinacea might
modestly reduce cold symptoms if begun when symptoms are
first noticed and continued for 7-10 days.
| Practice
Pearl |
| Tell patients with ragweed
allergies NOT to use echinacea. Echinacea and
ragweed have
cross-allergenicity. |
Elderberry (Sambucus
nigra) might be useful for treating the flu.
Elderberry has both antiviral and immunomodulating
effects. Elderberry seems to increase production of
inflammatory cytokines, such as interleukins and tumor
necrosis factor. It also seems to prevent viral
attachment to cells, similar to the neuraminidase
inhibitors. Elderberry is active against both influenza
A and B. The standardized elderberry extract, Sambucol, seems to
shorten the duration of symptoms such as fever and
myalgia when 4 tablespoons are taken daily for 3 days.
Tell patients that elderberry might reduce flu
symptoms.5260,10796 Caution patients not to
use uncooked elderberry fruit. The raw fruit contains
toxic compounds.
Patients may ask about a homeopathic
product, Oscillococcinum for
preventing and treating the flu. The rationale for its
use in influenza comes from the homeopathic principle of
"like cures like." Oscillococcinum is made from
very small doses of wild duck heart and liver, a
well-known source for influenza viruses. There's no
proof it prevents or treats influenza. Some researchers
might claim it reduces duration, but analysis of the
data shows only a one-fourth of a day
reduction.10804 This is not significant. Tell
patients not to waste their money.
One gram of vitamin C taken
PROPHYLACTICALLY seems to reduce the duration of cold
symptoms by about a half-day.6458 But these
doses are associated with a greater incidence of adverse
effects...nausea and diarrhea.4844 Taking 1
gram or 3 grams of vitamin C daily for two days at the
ONSET of cold symptoms doesn't seem to have any effect
on symptom severity or duration.9833 Tell
patients the slight reduction in duration of cold
symptoms isn't worth taking gram doses of vitamin C.
Research is divided on zinc for treating colds. A
lot of research suggests that zinc lozenges providing
9-24 mg elemental zinc per dose begun within 24-48 hours
of the onset of cold symptoms reduces the severity and
duration of
colds.333,334,335,336,337,6703,6705 But other
research shows no effect.338,
339,6521,6522,6700 Tell adult patients zinc
lozenges might be worth a try. But patients have to use
a zinc lozenge every 2-3 hours while awake. Zinc may
produce a dry or astringent feeling in the
mouth.10864
Studies using zinc lozenges in children
show conflicting conclusions.341,10803 It's
too soon to recommend zinc lozenges for children.
People also use zinc in nasal
formulations. Zinc SULFATE nasal sprays don't seem to
help cold symptoms.8629 Zinc GLUCONATE nasal
gel (Zicam) in a total
daily dose of 2.1 mg seems to lessen the severity and
shorten the duration of cold symptoms by up to
75%.6471,10247 But other evidence suggests it
has no effect on cold symptoms.8628 Tell
patients who want to try zinc gluconate nasal gel to
begin using it within 24-48 hours of symptom onset and
continue for the duration of cold symptoms.
Lots of other natural products are used to
treat colds and flu...goldenseal, pau d'arco, astragalus, larch arabinogalactan, propolis, boneset, wild indigo, and Siberian ginseng. These
products are marketed as "immune system supporters."
They are used alone or in combination with other natural
products, such as echinacea. But there's no reliable
clinical evidence that they relieve cold symptoms.
Theoretically, natural products that stimulate the
immune system could exacerbate autoimmune diseases. They
could also interfere with immunosuppressants, such as
cyclosporine (Sandimmune).
Miscellaneous
Saline nasal sprays or drops are
sometimes recommended as a benign cold treatment. But
most studies using nasal irrigation are in patients with
allergic rhinitis, sinusitis, or nasal
surgery.11108 Two-percent saline doesn't seem
to improve nasal symptoms in cold sufferers any better
than normal saline (0.9%).11109 There are no
studies showing saline nasal irrigation lessens the
severity or shortens the duration of cold symptoms. Tell
patients saline sprays don't seem to help cold
symptoms.
Teas are often promoted for cold and flu
symptoms. Elderflower, rose hip, goldenseal, German chamomile, peppermint, slippery elm, ginger, Mormon tea, linden flowers, meadowsweet, and other herbs
are used. The hot liquid may be soothing, but there's no
reliable evidence for efficacy. In fact, research
suggests hot, humidified air doesn't affect cold
symptoms.10805 The origin of the myth,
"feed a cold, starve a fever" is unknown. Some research
suggests chicken soup might have a mild
anti-inflammatory effect.10806 But there are
no clinical studies supporting the use of specific kinds
or quantities of food to treat colds or fever. Various
ethanol-containing concoctions are proposed for treating
colds and flu. Epidemiological research suggests that
light to moderate consumption of wine, particularly red wine,
can prevent colds.10807 But clinical research
suggests that acute ingestion of moderate amounts of red
wine, red grape juice, and ethanol doesn't have any
effect on immune function.10808 Tell patients
dietary interventions might provide psychological
comfort, but they don't seem to affect cold and flu
symptoms.
| |
|
 |
|
|
 |
|
|
 |
| Question
#8 |
| Oscillococcinum |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
|
|
 |
| Question
#9 |
| A patient asks you
about natural products for his cold symptoms. He
says he's "allergic to everything," including
dust, ragweed, and cats. Which of the following
should you tell the patient to avoid? |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
|
|
 |
| Question
#10 |
| Natural medicines that
might stimulate the immune system should be used
with caution in which situation? |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
|
| | |
| The Bottom Line |
 |
| |
Conventional medicine doesn't have a lot
to offer for cold prevention. Despite their popular use
for colds and flu prevention, echinacea, vitamin C, and zinc don't prevent colds. Some
evidence suggests Panax ginseng might
improve response to influenza immunization.
Treatment of colds and flu is a huge
market for both conventional symptomatic treatments and
natural medicines. Echinacea and andrographis might reduce the
duration and severity of cold symptoms. Tell patients to
begin using them at the first sign of a cold. Elderberry seems to lessen the
severity of influenza, but encourage high-risk patients,
such as the elderly, to seek proven conventional
treatment.
Vitamin C taken continuously
seems to reduce the duration of cold symptoms by less
than a day. Zinc lozenges or nasal spray
might reduce the severity and duration of colds if begun
within 24-48 hours of symptom onset. Avoiding illness
in the first place exceeds the best cold and flu cures
available. Encourage flu immunization. For patients who
don't like shots, the intranasal flu vaccine is a
possibility. Remind patients about simple cold
prevention tactics. Avoid people with colds as much as
possible. Wash hands frequently, especially when around
those infected when in public places or around patients.
Avoid touching the eyes or nose to prevent
self-inoculation of cold viruses.
| |
|
|
| |
|
|
|
| |
Recommendation chart for Natural Medicines
used for Colds and Flu * Prevention | |
|
|
| |
Recommendation chart for Natural Medicines
used for Colds and Flu * Treatment | |
|
|
 |
| KEY: |
 |
Consider recommending this product. |
 |
 |
 |
 |
 |
Don't recommend using this product. |
 |
 |
 |
 |
 |
Recommend against using this product. |
 |
 | |
* These proposed recommendations are based solely
on the Safety and Effectiveness Ratings contained in
Natural Medicines Comprehensive Database. This assumes
use of high-quality, uncontaminated products and the use of
typical doses. Keep in mind that some products are never
appropriate for some patients due to concomitant disease
states, potential drug interactions, or other clinical
factors. Use your clinical judgment before recommending any
product.
|
| 333 |
Mossad SB, Macknin ML, Medendorp SV, Mason P.
Zinc gluconate lozenges for treating the common cold. A
randomized, double-blind, placebo-controlled study. Ann Intern Med 1996;125:81-8. |
| 334 |
Godfrey JC, Conant Sloane B, Smith DS, et al.
Zinc gluconate and the common cold: a controlled clinical
study. J Int Med Res 1992;20:234-6. |
| 335 |
Al-Nakib W, Higgins PG, Barrow I, et al.
Prophylaxis and treatment of rhinovirus colds with zinc
gluconate lozenges. J Antimicrob Chemother
1987;20:893-901. |
| 336 |
Eby GA, Davis DR, Halcomb WW. Reduction in
duration of common colds by zinc gluconate lozenges in a
double-blind study. Antimicrob Agents Chemother
1984;25:20-4. |
| 337 |
Farr BM, Conner EM, Betts RF, et al. Two
randomized controlled trials of zinc gluconate lozenge therapy
of experimentally induced rhinovirus colds. Antimicrob Agents Chemother
1987;31:1183-7. |
| 338 |
Smith DS, Helzner EC, Nuttall CE Jr, et al.
Failure of zinc gluconate in treatment of acute upper
respiratory tract infections. Antimicrob Agents Chemother
1989;33:646-8. |
| 339 |
Weismann K, Jakobsen JP, Weismann JE, et al.
Zinc gluconate lozenges for common cold. A double-blind
clinical trial. Dan Med Bull 1990;37:279-81. |
| 341 |
Macknin ML, Piedmonte M, Calendine C, et al.
Zinc gluconate lozenges for treating the common cold in
children: a randomized, controlled trial. JAMA 1998;279:1962-7. |
| 589 |
Scaglione F, Cattaneo G, Alessandria M, Cogo
R. Efficacy and safety of the standardized Ginseng extract
G115 for potentiating vaccination against the influenza
syndrome and protection against the common cold. Drugs Exp Clin Res 1996;22:65-72. |
| 616 |
Sunter WH. Warfarin and garlic. Pharm J
1991;246:722. |
| 1412 |
Brinkeborn RM, Shah DV, Degenring FH.
Echinaforce and other Echinacea fresh plant preparations in
the treatment of the common cold. A randomized, placebo
controlled, double-blind clinical trial. Phytomedicine 1999;6:1-6. |
| 1963 |
Leibovitz B, Siegel BV. Ascorbic acid and the
immune response. Adv Exp Med Biol 1981;135:1-25. |
| 1965 |
Vilter RW. Nutritional aspects of ascorbic
acid: uses and abuses. West J Med 1980;133:485-92. |
| 1967 |
Pitt HA, Costrini AM. Vitamin C prophylaxis in
marine recruits. JAMA 1979;241:908-11. |
| 2744 |
Caceres DD, Hancke JL, Burgos RA, et al. Use
of visual analogue scale measurements (VAS) to assess the
effectiveness of standardized Andrographis paniculata extract
SHA-10 in reducing the symptoms of common cold. A randomized,
double-blind, placebo study. Phytomedicine 1999;6:217-23. |
| 2766 |
Puri A, Saxena R, Saxena RP, et al.
Immunostimulant agents from Andrographis paniculata. J Nat Prod 1993;56:995-9. |
| 2772 |
Caceres DD, Hancke JL, Burgos RA, Wikman GK.
Prevention of common colds with Andrographis Paniculata dried
extract: a pilot, double-blind trial. Phytomedicine
1997;4:101-4. |
| 2773 |
Melchior J, Palm S, Wikman G. Controlled
clinical study of standardized Andrographis paniculata in
common cold- a pilot trial. Phytomedicine
1996;97;3:315-8. |
| 2774 |
Hancke J, Burgos R, Caceres D, Wikman G. A
double-blind study with a new monodrug Kan Jang: decrease of
symptoms and improvement in the recovery from common colds.
Phytotherapy Res 1995;9:559-62. |
| 3042 |
Levine M, Rumsey SC, Daruwala R, et al.
Criteria and recommendations for vitamin C intake. JAMA 1999;281:1415-23. |
| 3281 |
Barrett B, Vohmann M, Calabrese C. Echinacea
for upper respiratory infection. J Fam Pract 1999;48:628-35. |
| 3282 |
Grimm W, Muller HH. A randomized controlled
trial of the effect of fluid extract of Echinacea purpurea on
the incidence and severity of colds and respiratory
infections. Am J Med 1999;106:138-43. |
| 3713 |
Chu DT, Wong WL, Mavligit GM. Immunotherapy
with Chinese medicinal herbs. II. Reversal of
cyclophosphamide-induced immune suppression by administration
of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 1988;25:125-9. |
| 4239 |
Ondrizek RR, Chan PJ, Patton WC, King A.
Inhibition of human sperm motility by specific herbs used in
alternative medicine. J Assist Reprod Genet
1999;16:87-91. |
| 4240 |
Ondrizek RR, Chan PJ, Patton WC, King A. An
alternative medicine study of herbal effects on the
penetration of zona-free hamster oocytes and the integrity of
sperm deoxyribonucleic acid. Fertil Steril 1999;71:517-22. |
| 4399 |
Pelto L, Ioslauri E, Lilius EM, et al.
Probiotic bacteria down-regulate the milk-induced inflammatory
response in milk-hypersensitive subjects but have an
immunostimulatory effect in healthy subjects. Clin Exp Allergy 1998;28:1474-9. |
| 4802 |
Kiesewetter H, Jung F, Jung EM, et al. Effect
of garlic on platelet aggregation in patients with increased
risk of juvenile ischaemic attack. Eur J Clin Pharmacol 1993;45:333-6. |
| 4803 |
Legnani C, Frascaro M, Guazzaloca G, et al.
Effects of a dried garlic preparation on fibrinolysis and
platelet aggregation in healthy subjects. Arzneimittelforschung
1993;43:119-22. |
| 4844 |
Food and Nutrition Board, Institute of
Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E,
Selenium, and Carotenoids. Washington, DC: National Academy
Press, 2000. Available at:
http://www.nap.edu/books/0309069351/html/. |
| 5260 |
Zakay-Rones Z, Varsano N, Zlotnik M, et al.
Inhibition of several strains of influenza virus in vitro and
reduction of symptoms by an elderberry extract (Sambucus nigra
L.) during an outbreak of influenza B Panama. J Altern Complement Med
1995;1:361-9. |
| 5784 |
Melchoir J, Spasov AA, Ostrovskij OV, et al.
Double-blind, placebo-controlled pilot and phase III study of
activity of standardized Andrographis paniculata Herba Nees
extract fixed combination (Kan Jang) in the treatment of
uncomplicated upper-respiratory tract infection. Phytomedicine 2000;7:341-50. |
| 6384 |
Lindenmuth GF, Lindenmuth EB. The efficacy of
echinacea compound herbal tea preparation on the severity and
duration of upper respiratory and flu symptoms: a randomized,
double-blind, placebo-controlled study. J Altern Complement Med
2000;6:327-34. |
| 6386 |
Melchart D, Walther E, Linde K, et al.
Echinacea root extracts for the prevention of upper
respiratory tract infections: a double-blind,
placebo-controlled randomized trial. Arch Fam Med 1998;7:541-5. |
| 6388 |
Luettig B, Steinmuller C, Gifford GE, et al.
Macrophage activation by the polysaccharide arabinogalactan
isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst 1989;81:669-75. |
| 6389 |
Stimpel M, Proksch A, Wagner H, et al.
Macrophage activation and induction of macrophage cytotoxicity
by purified polysaccharide fractions from the plant Echinacea
purpurea. Infect Immun 1984;46:845-9. |
| 6392 |
Henneicke-von Zepelin H, Hentschel C,
Schnitker J, et al. Efficacy and safety of a fixed combination
phytomedicine in the treatment of the common cold (acute viral
respiratory tract infection): results of a randomised, double
blind, placebo-controlled, multicentre study. Curr Med Res Opin 1999;15:214-27. |
| 6458 |
Douglas RM, Chalker EB, Treacy B. Vitamin C
for preventing and treating the common cold. Cochrane Database Syst Rev
2000;2:CD000980. |
| 6471 |
Hirt M, Nobel S, Barron E. Zinc nasal gel for
the treatment of common cold symptoms: A double-blind,
placebo-controlled trial. Ear Nose Throat J 2000;79:778-82. |
| 6521 |
Marshall I. Zinc for the common cold. Cochrane Database Syst Rev
2000;CD001364. |
| 6522 |
Jackson JL, Lesho E, Peterson C. Zinc and the
common cold: a meta-analysis revisited. J Nutr 2000;130:1512S-5S. |
| 6553 |
Girodon F, Galan P, Monget AL, et al. Impact
of trace elements and vitamin supplementation on immunity and
infections in institutionalized elderly patients: a
randomized, controlled trial. MIN. VIT. AOX. geriatric
network. Arch Intern Med 1999;159:748-54. |
| 6700 |
Douglas RM, Miles HB, Moore BW, et al. Failure
of effervescent zinc acetate lozenges to alter the course of
upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother
1987;31:1263-5. |
| 6703 |
Prasad AS, Fitzgerald JT, Bao B, et al.
Duration of symptoms and plasma cytokine levels in patients
with the common cold treated with zinc acetate. A randomized,
double-blind, placebo-controlled trial. Ann Intern Med 2000;133:245-52. |
| 6705 |
Petrus EJ, Lawson KA, Bucci LR, Blum K.
Randomized, double-masked, placebo-controlled clinical study
of the effectiveness of zinc acetate lozenges on common cold
symptoms in allergy-tested subjects. Curr Ther Res
1998;59:595-607. |
| 7756 |
Gill HS, Rutherfurd KJ. Probiotic
supplementation to enhance natural immunity in the elderly:
effects of a newly characterized immunostimulatory strain of
Lactobacillus rhamnosus HN001 (DR20) on leucocyte
phagocytosis. Nutr Res 2001;21:183-9. |
| 7757 |
Sheih YH, Chiang BL, Wang LH, et al. Systemic
immunity-enhancing effects in healthy subjects following
dietary consumption of the lactic acid bacterium Lactobacillus
rhamnosus HN001. J Am Coll Nutr 2001;20:149-56. |
| 8228 |
Turner RB, Riker DK, Gangemi JD.
Ineffectiveness of echinacea for prevention of experimental
rhinovirus colds. Antimicrob Agents Chemother
2000;44:1708-9. |
| 8565 |
Hatakka K, Savilahti E, Ponka A, et al. Effect
of long term consumption of probiotic milk on infections in
children attending day care centres: double blind, randomised
trial. BMJ 2001;322:1327. |
| 8628 |
Turner RB. Ineffectiveness of intranasal zinc
gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis 2001;33:1865-70. |
| 8629 |
Belongia EA, Berg R, Liu K. A randomized trial
of zinc nasal spray for the treatment of upper respiratory
illness in adults. Am J Med 2001;111:103-8. |
| 9832 |
Carr AB, Einstein R, Lai LY, et al. Vitamin C
and the common cold: using identical twins as controls. Med J Aust 1981;2:411-2. |
| 9833 |
Audera C, Patulny RV, Sander BH, Douglas RM.
Mega-dose vitamin C in treatment of the common cold: a
randomized controlled trial. Med J Aust 2001;175:359-62. |
| 10247 |
Mossad SB. Effect of zincum gluconicum nasal
gel on the duration and symptom severity of the common cold in
otherwise healthy adults. QJM 2003;96:35-43. |
| 10762 |
National Institute of Allergy and Infectious
Diseases. The Common Cold.
http://www.niaid.nih.gov/factsheets/cold.htm (Accessed 28
August 2003). |
| 10763 |
Gwaltney JM Jr. The Common Cold. In:
Principles and Practices of Infectious Diseases, 5th ed.
Mandell GL, Bennett JE, Dolin R, eds. New York, NY: Churchill
Livingstone; 2000. pgs. 651-6. |
| 10764 |
National Institute of Allergy and Infectious
Diseases. Flu. http://www.niaid.nih.gov/factsheets/flu.htm
(Accessed 28 August 2003). |
| 10765 |
Savolainen C, Blomqvist S, Hovi T. Human
rhinoviruses. Paediatr Respir Rev 2003;4:91-8. |
| 10766 |
Heikkinen T, Jarvinen A. The common cold. Lancet 2003;361:51-9. |
| 10767 |
Treanor, JJ. Influenza virus. In: Principles
and Practices of Infectious Diseases, 5th ed. Mandell GL,
Bennett JE, Dolin R, eds. New York, NY: Churchill Livingstone;
2000. pgs. 1823-49. |
| 10768 |
Gwaltney JM Jr, Hayden FG. Psychological
stress and the common cold. N Engl J Med 1992;326:644-5. |
| 10769 |
Bensenor IM, Cook NR, Lee IM, et al. Active
and passive smoking and risk of colds in women. Ann Epidemiol 2001;11:225-31. |
| 10770 |
National Institute of Allergy and Infectious
Diseases. Is it a Cold or the Flu?
http://www.niaid.nih.gov/publications/cold/sick.pdf (Accessed
29 August 2003). |
| 10771 |
Cohen S, Tyrrell DA, Smith AP. Psychological
stress and susceptibility to the common cold. N Engl J Med 1991;325:606-12. |
| 10772 |
Takkouche B, Regueira C, Gestal-Otero JJ. A
cohort study of stress and the common cold. Epidemiology 2001;12:345-9. |
| 10773 |
Bridges CB, Harper SA, Fukuda K, et al.
Prevention and control of influenza: Recommendations of the
Advisory Committee on Immunization Practices (ACIP). MMWR
Recomm Rep 2003:52(RR-8);1-34. Available at:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5208a1.htm
(Accessed 30 August 2003). |
| 10774 |
FDA News: First Nasal Mist Flu Vaccine
Approved. June 17, 2003.
http://www.fda.gov/bbs/topics/NEWS/2003/NEW00913.html
(Accessed 30 August 2003). |
| 10775 |
Couch RB. Prevention and treatment of
influenza. N Engl J Med 2000;343:1778-87. |
| 10776 |
Cooper NJ, Sutton AJ, Abrams KR, et al.
Effectiveness of neuraminidase inhibitors in treatment and
prevention of influenza A and B: systematic review and
meta-analyses of randomised controlled trials. BMJ 2003;326:1235. |
| 10777 |
Sun Y, Hersh EM, Lee SL, et al. Preliminary
observations on the effects of the Chinese medicinal herbs
Astragalus membranaceus and Ligustrum lucidum on lymphocyte
blastogenic responses. J Biol Response Mod 1983;2:227-37. |
| 10780 |
Takkouche B, Regueira-Mendez C, Garcia-Closas
R, et al. Intake of vitamin C and zinc and risk of common
cold: a cohort study. Epidemiology 2002;13:38-44. |
| 10782 |
Melchart D, Linde K, Fischer P, Kaesmayr J.
Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev
2000;2:CD000530. |
| 10783 |
Turner RB. The treatment of rhinovirus
infections: progress and potential. Antiviral Res 2001;49:1-14. |
| 10784 |
Turner RB, Cetnarowski WE. Effect of treatment
with zinc gluconate or zinc acetate on experimental and
natural colds. Clin Infect Dis 2000;31:1202-8. |
| 10785 |
Venuta A, Spano C, Laudizi L, et al. Essential
fatty acids: the effects of dietary supplementation among
children with recurrent respiratory infections. J Int Med Res 1996;24:325-30. |
| 10786 |
Kew S, Banerjee T, Minihane AM, et al. Lack of
effect of foods enriched with plant- or marine-derived n-3
fatty acids on human immune function. Am J Clin Nutr 2003;77:1287-95. |
| 10787 |
Josling P. Preventing the common cold with a
garlic supplement: a double-blind, placebo-controlled survey.
Adv Ther 2001;18:189-93. |
| 10788 |
Graat JM, Schouten EG, Kok FJ. Effect of daily
vitamin E and multivitamin-mineral supplementation on acute
respiratory tract infections in elderly persons: a randomized
controlled trial. JAMA 2002;288:715-21. |
| 10791 |
Matheson NJ, Symmonds-Abrahams M, Sheikh A, et
al. Neuraminidase inhibitors for preventing and treating
influenza in children. Cochrane Database Syst Rev
2003;(3):CD002744. |
| 10792 |
Sutter AI, Lemiengre M, Campbell H, Mackinnon
HF. Antihistamines for the common cold. Cochrane Database Syst Rev
2003;3:CD001267. |
| 10793 |
Hayden FG, Diamond L, Wood PB, et al.
Effectiveness and safety of intranasal ipratropium bromide in
common colds. A randomized, double-blind, placebo-controlled
trial. Ann Intern Med 1996;125:89-97. |
| 10794 |
Schroeder K, Fahey T. Over-the-counter
medications for acute cough in children and adults in
ambulatory settings. Cochrane Database Syst Rev
2001;(3):CD001831. |
| 10795 |
Gabrielian ES, Shukarian AK, Goukasova GI, et
al. A double blind, placebo-controlled study of Andrographis
paniculata fixed combination Kan Jang in the treatment of
acute upper respiratory tract infections including sinusitis.
Phytomedicine 2002;9:589-97. |
| 10796 |
Barak V, Halperin T, Kalickman I. The effect
of Sambucol, a black elderberry-based, natural product, on the
production of human cytokines: I. Inflammatory cytokines. Eur Cytokine Netw 2001;12:290-6. |
| 10797 |
Schwarz E, Metzler J, Diedrich JP, et al. Oral
administration of freshly expressed juice of Echinacea
purpurea herbs fail to stimulate the nonspecific immune
response in healthy young men: results of a double-blind,
placebo-controlled crossover study. J Immunother 2002;25:413-20. |
| 10798 |
Tragni E, Tubaro A, Melis S, Galli CL.
Evidence from two classic irritation tests for an
anti-inflammatory action of a natural extract, Echinacina B.
Food Chem Toxicol 1985;23:317-9. |
| 10799 |
Muller-Jakic B, Breu W, Probstle A, et al. In
vitro inhibition of cyclooxygenase and 5-lipoxygenase by
alkamides from Echinacea and Achillea species. Planta Med 1994;60:37-40. |
| 10800 |
Barrett BP, Brown RL, Locken K, et al.
Treatment of the common cold with unrefined echinacea. A
randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002;137:939-46. |
| 10802 |
Schulten B, Bulitta M, Ballering-Bruhl B, et
al. Efficacy of Echinacea purpurea in patients with a common
cold. A placebo-controlled, randomised, double-blind clinical
trial. Arzneimittelforschung
2001;51:563-8. |
| 10803 |
McElroy BH, Miller SP. Effectiveness of zinc
gluconate glycine lozenges (Cold-Eeze) against the common cold
in school-aged subjects: a retrospective chart review. Am J Ther 2002;9:472-5. |
| 10804 |
Vickers AJ, Smith C. Homoeopathic
Oscillococcinum for preventing and treating influenza and
influenza-like syndromes. Cochrane Database Syst Rev
2000;2:CD001957. |
| 10805 |
Singh M. Heated, humidified air for the common
cold. Cochrane Database Syst Rev
2001;(4):CD001728. |
| 10806 |
Rennard BO, Ertl RF, Gossman GL, et al.
Chicken soup inhibits neutrophil chemotaxis in vitro. Chest 2000;118:1150-7. |
| 10807 |
Takkouche B, Regueira-Mendez C, Garcia-Closas
R, et al. Intake of wine, beer, and spirits and the risk of
clinical common cold. Am J Epidemiol 2002;155:853-8. |
| 10808 |
Watzl B, Bub A, Briviba K, Rechkemmer G. Acute
intake of moderate amounts of red wine or alcohol has no
effect on the immune system of healthy men. Eur J Nutr 2002;41:264-70. |
| 10861 |
Levine M, Beattie BL, McLean DM. Comparison of
one- and two-dose regimens of influenza vaccine for elderly
men. CMAJ 1987;137:722-6. |
| 10862 |
Gross PA, Weksler ME, Quinnan GV Jr, et al.
Immunization of elderly people with two doses of influenza
vaccine. J Clin Microbiol 1987;25:1763-5. |
| 10863 |
Widmer AF. Replace hand washing with use of a
waterless alcohol hand rub? Clin Infect Dis 2000;31:136-43. |
| 10864 |
Eby GA. Elimination of efficacy by additives
in zinc acetate lozenges for common colds. Clin Infect Dis 2001 May
15;32(10):1520. |
| 10865 |
Sattar SA, Abebe M, Bueti AJ, et al. Activity
of an alcohol-based hand gel against human adeno-, rhino-, and
rotaviruses using the fingerpad method. Infect Control Hosp Epidemiol
2000;21:516-9. |
| 11101 |
Arroll B, Kenealy T. Antibiotics for the
common cold. Cochrane Database Syst Rev
2002;(3):CD000247. |
| 11102 |
Dowell SF, Marcy SM, Phillips WR, et al.
Principles of judicious use of antimicrobial agents for
pediatric upper respiratory tract infections. Pediatrics
1998;101:163-5. |
| 11103 |
Gonzales R, Bartlett JG, Besser RE, et al.
Principles of appropriate antibiotic use for treatment of
acute respiratory tract infections in adults: background,
specific aims, and methods. Ann Intern Med 2001;134:479-86. |
| 11104 |
Sperber SJ, Hendley JO, Hayden FG, et al.
Effects of naproxen on experimental rhinovirus colds. A
randomized, double-blind, controlled trial. Ann Intern Med 1992;117:37-41. |
| 11105 |
Gwaltney JM Jr. Combined antiviral and
antimediator treatment of rhinovirus colds. J Infect Dis 1992;166:776-82. |
| 11106 |
Winther B, Mygind N. The therapeutic
effectiveness of ibuprofen on the symptoms of naturally
acquired common colds. Am J Rhinol 2001;15:239-42. |
| 11107 |
Dales RE, Lunau MA, Tierney MG, Schweitzer I.
Chronic cough responsive to ibuprofen. Pharmacotherapy 1992;12:331-3. |
| 11108 |
Papsin B, McTavish A. Saline nasal irrigation:
Its role as an adjunct treatment. Can Fam Physician 2003;49:168-73. |
| 11109 |
Adam P, Stiffman M, Blake RL Jr. A clinical
trial of hypertonic saline nasal spray in subjects with the
common cold or rhinosinusitis. Arch Fam Med 1998;7:39-43. |
| 11110 |
Freestone C, Eccles R. Assessment of the
antitussive efficacy of codeine in cough associated with
common cold. J Pharm Pharmacol
1997;49:1045-9. | |
|
| |
|